450
Participants
Start Date
January 1, 2021
Primary Completion Date
September 1, 2024
Study Completion Date
September 1, 2032
Freedom® Total Knee System
To evaluate the survivorship, safety and performance of the Freedom® Total Knee System in the treatment of subjects who in the surgeon's opinion require a primary total knee replacement due to severe knee joint pain and loss of mobility due to osteoarthritis, rheumatoid arthritis or post-traumatic arthritis.
Lead Sponsor
Meril Life Sciences Pvt. Ltd.
INDUSTRY